By downmodulating Bmi1 in primary AML CD34+ cells, they found that progenitor and stem cell frequencies were reduced, and this was associated with increased expression of p14ARF and p16INK4A as well as an enriched level of intracellular reactive oxygen species. The gene discussed is CD34; the disease is acute myeloid leukemia.